Altered binding avidities and improved growth inhibitory effects of novel anti-HER3 mAb against human cancers in the presence of HER1-or HER2-targeted drugs.
Biochem Biophys Res Commun
; 576: 59-65, 2021 10 22.
Article
in En
| MEDLINE
| ID: mdl-34482024
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptor, ErbB-2
/
Receptor, ErbB-3
/
Antibodies, Monoclonal
/
Neoplasms
Limits:
Animals
/
Humans
Language:
En
Journal:
Biochem Biophys Res Commun
Year:
2021
Document type:
Article
Affiliation country:
Japón
Country of publication:
Estados Unidos